DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting

NAUnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

February 28, 2010

Conditions
Reduced Left Ventricular Function Defined as LVEF < 50%Regional Left Ventricular Wall Motion Abnormalities
Interventions
PROCEDURE

Direct Epicardial Shock Wave Therapy

performed in adjunct to a standard coronary artery bypass grafting procedure Prior to aortic cross clamping direct epicardial shock wave therapy - applied directly to the myocardium

Trial Locations (1)

1090

Clinical Department for Cardiothoracic Surgery, General Hospital Vienna, Vienna

All Listed Sponsors
lead

Cardiac Regeneration Technologies, LLC

INDUSTRY

NCT00741065 - DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting | Biotech Hunter | Biotech Hunter